Decreased expression of mac25 mRNA in uterine leiomyomata compared with adjacent myometrium

American Journal of Reproductive Immunology

Volumn 43, Issue 1, 2000, Pages 53-57

  Kim, Jung Gu ^a   Kim, Myung Hee ^a   Kim, Ik Sang ^b   Moon, Shin Yong ^a   Kang, Soon Beom ^a   Lee, Hyo Pyo ^a   Lee, Jin Yong ^a  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

GnRHa; Mac25; Uterine leiomyomata

Indexed keywords

GONADORELIN; GOSERELIN; MAC25; MESSENGER RNA; SOMATOMEDIN BINDING PROTEIN; UNCLASSIFIED DRUG;

ADULT; CANCER INHIBITION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MENSTRUAL CYCLE; MYOMETRIUM; NORTHERN BLOTTING; PATHOGENESIS; PRIORITY JOURNAL; UTERUS MYOMA;

EID: 0033960172     PISSN: 10467408     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.8755-8920.2000.430110.x     Document Type: Conference Paper

References (21)

1. Adesyana OO, Zhou J, Bomdy CA: Sex steroid regulation of IGF system gene expression and proliferation in primate myometrium. J Clin Endocrinol Metab 1996; 81:1967-1974.
2. Vollenhoven BJ, Herington AC, Healy DL: Messenger ribonucleic acid expression of the insulin-like growth factors and their binding proteins in uterine fibroids and myometrium. J Clin Endocrinol Metab 1993; 76:1106-1110.
3. Giudice LC, Irwin JC, Dsupin BA, Pannier EM, Jin IH, Hoffman AR: Insulin-like growth factor (IGF), IGF binding protein (IGFBP), and IGF receptor gene expression and IGFBP synthesis in human uterine leiomyomata. Human Reprod 1993; 8:1796-1806.
4. Tang XM, Rossi MJ, Masterson BJ, Chegini N: Insulin-like growth factor I (IGF-I), IGF-I receptors, and IGF binding proteins 1-4 in human uterine tissues: Tissue localization and IGF-I action in endometrial stromal and myometrial smooth muscle cells in vitro. Biol Reprod 1994; 50:1113-1125.
5. Van Der Ven LTM, Gloudesmans T, Roholl PJM, Van Buul-Offers SC, Bladergroen BA, Welters MJP, Sussenbach JS, Otter WD: Growth advantage of human leiomyoma cells compared to normal smooth muscle cells due to enhanced sensitivity toward insulin-like growth factor I. Int J Cancer 1994; 59:427-434.
6. Oh Y, Yamanaka Y, Kim H, Veorwek P, Wilson E, Hwa V, Yang D, Spagnoli A, Wanek D, Rosenfeld RG: IGF-independent action of IGFBPs. In Molecular Mechanisms to Regulate the Activities of Insulin-like Growth Factors, K Takano, N Hizuka, S Takahashi (eds). Tokyo, Elsevier, 1998, pp 125-133.
7. Baxter RC, Binoux MA, Clemmons DR, Conover CA, Drop SLS, Holly JMP, Mohan S, Rosenfeld RG: Recommendations for nomenclature of the insulin-like growth factor binding protein superfamily. J Clin Endocrinol Metab 1998; 53:3213.
8. Murphy M, Pykett MJ, Harnish P, Zang KD, George DL: Identification and characterization of genes differentially expressed in meningiomas. Cell Growth Differ 1993; 4:715-722.
9. Swisshelm K, Ryan K, Tsuchiya K, Sager R: Enhanced expression of an insulin-like growth factor binding protein (mac25) in senescent human mammary epithelial cells and induced expression with retinoic acid. Proc Natl Acad Sci USA 1995; 92:4472-4476.
10. Burger AM, Zhang X, Li H, Ostrowski JL, Beatty B, Vennanzoni M, Papas T, Seth A: Down-regulation of T1A12/mac25, a novel insulin-like growth factor binding protein related gene, is associated with disease progression in breast carcinomas. Oncogene 1998; 16:2459-2467.
11. Kato MV, Sato H, Tsukada T, Ikawa Y, Aizawa S, Nagayoshi M: A follistatin-like gene, mac 25 may act as a growth suppressor of osteosarcoma cells. Oncogene 1996, 12:1361-1364.
12. Rutgers JL, Spong CY, Sinow R, Heiner J: Leuprolide acetate treatment and myoma arterial size. Obstet Gynecol 1995; 86:386-388.
13. Kobayashi Y, Zhal YL, Linuma M, Horiuchi A, Nikaido T, Fujii S: Effects of a GnRH analogue on human smooth muscle cells cultured from normal myometrial and from uterine leiomyoma tissues. Mol Hum Reprod 1997; 3:91-99.
14. Noyes RW, Hertig AT, Rock J: Dating the endometrial biopsy. Fertil Steril 1950; 1:3-25.
15. Damon SE, Hauk KL, Swisshelm K, Quinn LS: Developmental regulation of mac25/insulin-like growth factor binding-7 expression in skeletal myogenesis. Exp Cell Res 1997; 237:192-195.
16. Tamaya T, Fujimoto J, Okada H: Comparison of cellular level of steroid receptors in uterine leiomyomata and endometrium. Acta Obstet Gynecol Scand 1985; 64:307-309.
17. Marugo M, Centonze M, Bernasconi D, Fazzuli L, Berta SS, Giordano G: Estrogen and progesterone receptors in uterine leiomyomas. Acta Obstet Gynecol Scand 1989; 68:731-735.
18. Vollenhoven BJ, Pearce P, Herington AC, Healy DL: Steroid receptor binding and messenger RNA expression in fibroids from untreated and gonadotropin-releasing hormone agonist pretreated women. Clin Endocrinol 1994; 40:537-544.
19. Oh Y, Nagalla SR, Yamanaka Y, Kim H, Wilson E, Rosenfeld RG: Synthesis and characterization of insulin-like growth factor binding protein (IGFBP-7). J Biol Chem 1996; 29:30322-30325.
20. Crow J, Gardner RL, McSweeny G, Shaw RW: Morphological changes in uterine leiomyomas treated by GnRH agonist goserelin. Int J Gynecol Pathol 1995; 14:235-242.
21. Wilson EM, Oh Y, Rosenfeld RG: Generation and characterization of an IGFBP-7 antibody: Identification of 31kD IGFBP-7 in human biological fluids and Hs578T human breast cancer conditioned media. J Clin Endocrinol Metab 1997; 82:1301-1303.